Navigation Links
Goodwin Biotechnology is a Three-Category Winner in the 2012 CMO Leadership Awards
Date:10/25/2012

PLANTATION, Fla., Oct. 25, 2012 /PRNewswire/ -- Goodwin Biotechnology, Inc. (GBI) has been named a three-category winner in the 2012 CMO Leadership Awards presented by Life Science Leader magazine. GBI was rated in the top 20% for Innovation, Productivity and Regulatory.

"We at GBI are honored to be recognized in three categories of the CMO Leadership Awards, and consider it a testament to the quality of our people and their dedication to our customers," noted Bansi K. Bhan, Interim CEO at Goodwin Biotechnology, Inc.  "Regarding innovation, our scientists take great pride in identifying and implementing solutions to the most complex challenges. We are also proud of the Productivity award because we have established a history of meeting and exceeding our clients' expectations by consistently delivering on agreed upon objectives. Further, from a regulatory perspective, we focus on both quality and compliance as a single source for biologics development and manufacturing from cell line engineering and proof of concept through to cGMP manufacturing of late-stage clinical trial material."

Life Science Leader developed the annual CMO Leadership Awards in 2011 to honor top outsourcing industry performers based on leading research to better serve pharmaceutical and biopharmaceutical executives in the CMO vetting process. Life Science Leader partnered with the professional marketing research agency, Nice Insight, who created a methodology that combines the surveying of thousands of industry executives with other key analyses, such as review of marketing material, to facilitate better overall outsourcing collaborations.

Nice Insight is moving into its third year of conducting primary research on the outsourcing practices of pharmaceutical and biotechnology executives. For the 2012 CMO Leadership Awards survey, the sample size was over 10,000 executives who provided their perceptions on 170 contract manufacturing organizations (CMOs). The companies that service the drug development cycle were rated on six key drivers in outsourcing – Quality, Reliability, Productivity, Regulatory, Affordability, and Innovation. Leadership Award winners scored in the top 20% of all CMOs in each of the previously mentioned categories.

"At Life Science Leader, we think that data-driven awards are more objective and valuable than recognizing companies as a result of a nomination and voting process," shared Rob Wright, Editor in Chief, Life Science Leader. "The core of the research is focused on awareness, or how well a CMO and its service offering are known within the outsourcing industry, and customer perceptions, or how the business is regarded by the potential and current buyers of outsourced services.  The winners should be proud of these awards because they were determined by the perceptions of their target audiences."

About Goodwin Biotechnology, Inc.

Goodwin Biotechnology is a world-class CMO that offers fully integrated cGMP contract manufacturer of monoclonal antibodies, recombinant proteins and vaccines. GBI has the expertise and experience in cell line development, proof of concept, process development and GMP manufacturing of recombinant proteins and antibodies, as well as conjugated therapeutic proteins (e.g., antibodies conjugated to linkers for radioimmune therapy and diagnostics, other antibodies, proteins, chemotoxins, or plant toxins) by leveraging our proprietary conjugation technology. By working with GBI, our clients can enhance the value of their product candidates with clear development and manufacturing strategies and a road map to meet the highest quality product requirements from the milligram and gram range to kilogram quantities as the product candidates move along the clinical approval pathway in a cost-effective, timely and cGMP compliant manner to enhanced patients' lives. With 20 years of experience as an independent contract manufacturer, GBI has worked as a strategic partner with companies of all sizes from small university spin-offs to major research institutes, government agencies and large, established biopharmaceutical companies.

For more information, please contact:

Goodwin Biotechnology:
Dave Cunningham
Director of Marketing & Administration
(954) 327-9639
DCunningham@goodwinbio.com


'/>"/>
SOURCE Goodwin Biotechnology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Agricultural Biotechnology: Emerging Technologies and Global Markets
2. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
3. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
4. Antibiotics and Biotechnology Take Center Stage at Food Dialogues Event
5. TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine
6. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
7. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
8. Tina Fehr, Senior Product Manager For AmLactin, Upsher-Smith Laboratories Named PM360 Trailblazer Winner For Womens Health Brand Manager
9. Archbishop Desmond Tutu and the International Childrens Peace Prize Winners Launch Remember2015
10. Elsevier and Australasian Research Management Society Announce Winners of the 2012 Scopus Young Researcher of the Year Awards
11. Winner Medical Reports Third Quarter Fiscal 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... DUBLIN , Feb. 24, 2017 Research ... Health Market Analysis & Trends - Industry Forecast to 2025" ... ... at a CAGR of around 23.8% over the next decade to ... analyzes the market estimates and forecasts for all the given segments ...
(Date:2/24/2017)... Research and Markets has announced the addition of ... to 2025" report to their offering. ... The Global Empty Capsules Market is poised to grow ... approximately $2.9 billion by 2025. This industry report analyzes ... as well as regional levels presented in the research scope. The study ...
(Date:2/24/2017)... Research and Markets has announced the addition of the "Dry ... offering. ... Dry eye Drugs Price Analysis and Strategies - 2016, provides drug pricing ... answers the following questions: What are the ... they positioned in the Global Dry eye market? What ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the 10th ... Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on how ... management. , ODH will also have an exhibit booth where attendees may speak to ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide ... with a specific LRRK2 mutation, according to a study released today at the ... evidence of a link between pesticides and incidence of sporadic PD through occupational ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, ... Go. Core benefits and advantages built into the home office sit stand solution ... and feel. Ability to gain the benefits embedded in the TaskMate Go are ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release ... show in Cannes (France), XO Private has initiated a second print-run of its lavish ... almost a metre across when open, weighs in at more than six kilos, retails ...
Breaking Medicine News(10 mins):